Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M39,716Revenue $M4,104Net Margin (%)15.5Altman Z-Score14.8
Enterprise Value $M39,215EPS $5.5Operating Margin %30.5Piotroski F-Score7
P/E(ttm)75.1Beneish M-Score-2.1Pre-tax Margin (%)29.9Higher ROA y-yY
Price/Book10.810-y EBITDA Growth Rate %--Quick Ratio3.4Cash flow > EarningsY
Price/Sales11.45-y EBITDA Growth Rate %--Current Ratio3.6Lower Leverage y-yY
Price/Free Cash Flow71.0y-y EBITDA Growth Rate %46.9ROA % (ttm)13.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)20.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M104ROIC % (ttm)24.9Gross Margin Increase y-yN

Gurus Latest Trades with REGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
REGNVanguard Health Care Fund 2015-12-31 Reduce-0.17%$459.82 - $587.09
($543.11)
$ 379.01-30%Reduce -6.84%2,280,494
REGNMario Gabelli 2015-12-31 Reduce$459.82 - $587.09
($543.11)
$ 379.01-30%Reduce -35.76%1,378
REGNKen Fisher 2015-12-31 Add$459.82 - $587.09
($542.9)
$ 379.01-30%Add 22.02%615
REGNVanguard Health Care Fund 2015-09-30 Reduce-0.32%$451.82 - $592.4
($537.03)
$ 379.01-29%Reduce -11.45%2,447,894
REGNRon Baron 2015-09-30 Reduce$451.82 - $592.4
($537.03)
$ 379.01-29%Reduce -0.21%7,463
REGNKen Fisher 2015-09-30 Reduce$451.82 - $592.4
($537.03)
$ 379.01-29%Reduce -10.80%504
REGNVanguard Health Care Fund 2015-06-30 Reduce-0.15%$438.27 - $539.4
($487.44)
$ 379.01-22%Reduce -5.36%2,764,540
REGNMario Gabelli 2015-06-30 Reduce$438.27 - $539.4
($487.44)
$ 379.01-22%Reduce -2.05%2,145
REGNRon Baron 2015-06-30 Reduce$438.27 - $539.4
($487.44)
$ 379.01-22%Reduce -0.15%7,479
REGNKen Fisher 2015-06-30 Add$438.27 - $539.4
($487.44)
$ 379.01-22%Add 5.81%565
REGNKen Fisher 2015-03-31 Add$396.89 - $488.87
($423.8)
$ 379.01-11%Add 1.91%534
REGNVanguard Health Care Fund 2014-12-31 Add0.12%$328.07 - $434.95
($393.59)
$ 379.01-4%Add 4.49%2,921,000
REGNJoel Greenblatt 2014-12-31 Sold Out -0.01%$328.07 - $434.95
($394.04)
$ 379.01-4%Sold Out0
REGNJoel Greenblatt 2014-09-30 Add$296.41 - $364.41
($335.27)
$ 379.0113%Add 60.05%1,410
REGNKen Fisher 2014-09-30 Buy $296.41 - $364.41
($335.27)
$ 379.0113%New holding583
REGNVanguard Health Care Fund 2014-06-30 Add0.79%$277.29 - $313.74
($296.6)
$ 379.0128%Add 60.34%2,795,500
REGNJoel Greenblatt 2014-06-30 Buy $277.29 - $313.74
($296.6)
$ 379.0128%New holding881
REGNMario Gabelli 2014-06-30 Buy $277.29 - $313.74
($296.6)
$ 379.0128%New holding2,295
REGNVanguard Health Care Fund 2014-03-31 Add0.29%$267.62 - $347.62
($306.26)
$ 379.0124%Add 23.47%1,743,468
REGNRon Baron 2014-03-31 Buy 0.01%$267.62 - $347.62
($307.2)
$ 379.0123%New holding6,084
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

REGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


REGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2016-01-12Buy83,938$465.04-18.5view
McCorkle Douglas SVP Controller and Asst Treasur 2015-12-29Sell3,954$552.08-31.35view
BROWN MICHAEL SDirector 2015-12-10Sell3,000$546.45-30.64view
YANCOPOULOS GEORGEPresident Regeneron Laboratori 2015-12-02Sell43,348$549.03-30.97view
VAGELOS P ROYChairman of the Board 2015-11-18Sell17,240$587.9-35.53view
SING GEORGE LDirector 2015-11-18Sell3,500$580-34.65view
Van Plew Daniel PSVP & General Mgr Industrial O 2015-11-10Sell5,123$554.85-31.69view
STAHL NEILEVP Research and Development 2015-11-09Sell42,101$561.45-32.49view
VAGELOS P ROYChairman of the Board 2015-11-03Sell17,242$580.19-34.67view
YANCOPOULOS GEORGEPresident Regeneron Laboratori 2015-11-02Sell43,348$571.61-33.69view

Quarterly/Annual Reports about REGN:

News about REGN:

Articles On GuruFocus.com
Weekly CFO Sells Highlights: Facebook, Fitbit, Regeneron Pharmaceuticals Nov 23 2015 
The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings Nov 04 2015 
Weekly CFO Sells Highlight: Acadia Healthcare, Facebook, Regeneron Pharmaceuticals Aug 24 2015 
Weekly Insider Sells Highlights: FB, AET, REGN, TYC Aug 18 2015 
Brean Capital Weighs in on Medivation Following Update on TERRAIN Study Mar 26 2015 
Can These Three BioTech Companies Make It Big? Feb 20 2015 
J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
Weekly Insider Sells Highlight: REGN, HSP, TYC, AAPL Nov 30 2014 
S&P 500 Finishes Above 2,000 Aug 27 2014 
How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug Aug 20 2014 

More From Other Websites
Regeneron Pharmaceuticals’ Major Revenue Sources in 4Q15 Feb 12 2016
Bad News for Regeneron Pharmaceuticals for 4Q15 Revenue and Earnings Feb 12 2016
Express Scripts sees slow 2016 sales for new cholesterol drugs Feb 12 2016
REGENERON PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Feb 11 2016
Morgan Stanley is Wrong: This Biotech is Ready to Explode Higher Feb 11 2016
The Zacks Analyst Blog Highlights: Regeneron, Alexion, CTI BioPharma, BioCryst and Sarepta Feb 11 2016
Novartis And the Future Of Drug Pricing Feb 10 2016
Biotech Stock Roundup: Alexion, Regeneron Miss Estimates; Setback for CTI BioPharma Feb 10 2016
Regeneron Pharmaceuticals, Inc. Earnings Analysis: 2015 By the Numbers Feb 10 2016
Regeneron Q4 Earnings Miss Estimates Amid Slow Praluent Launch Feb 09 2016
[$$] Regeneron: Good Results, Great Expectations Feb 09 2016
Edited Transcript of REGN earnings conference call or presentation 9-Feb-16 1:30pm GMT Feb 09 2016
Regeneron Q4 Earnings Lag, Gives 2016 View for Eylea Sales Feb 09 2016
Regeneron sees gradual adoption of cholesterol drug Praluent Feb 09 2016
Regeneron: Get Used to Disappointment Feb 09 2016
US STOCKS-Wall St turn positive after weak start as tech rebounds Feb 09 2016
Stocks to Watch: Regeneron, Sears, Coke, XPO Feb 09 2016
Regeneron Falls on Missed Earnings Feb 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK